AMGN today
$468.11+$2.88 (+0.62%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bullish
1 hourLeaning Bullish
15 minAscending Triangle
5 minConsolidating
Daily trend turns down below $374.46
Key levels
Resistance$475.64
Support$447.04
Support$424.74
Latest news & SEC filings
ProductAmgen says late-stage trial of dazodalibep met goals in Sjögren's disease
ProductAmgen experimental drug reduces symptoms in chronic autoimmune disease affecting tear production
ProductAmgen reports dazodalibep hit its primary endpoint at week 48
ProductAmgen reports findings for Repatha at 2026 AHA Scientific Sessions
All AMGN news →About Amgen
Amgen is a biotechnology company that discovers, develops, manufactures, and markets human therapeutics. Its products include medicines for oncology, cardiovascular disease, bone health, inflammation, and nephrology, sold to healthcare providers, hospitals, and patients worldwide. The company operates research, manufacturing, and commercial sites across the United States, Europe, and other international markets.
Based on the company's 10-K filed Feb 13, 2026.
Nasdaq · Healthcare
AMGEN INC (AMGN)
What Is the Price Target for AMGN?
SEPT Low Target
$398.00
SEPT Mid Target
$464.50
SEPT High Target
$536.00
Analyst Consensus
$464.50
Is AMGN a Buy or Sell Right Now?
Thesis
- •Revenue growing 9.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AMGN.
Start Free Trial →Is AMGN Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$507.12
46
Moat Score
NARROW
5/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with AMGN?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
BUYING
8 buys / 12 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| MILES AMY E | director | Buy | 665 | - | May 19, 2026 |
| Kullman Ellen Jamison | director | Buy | 665 | - | May 19, 2026 |
| Klotman Mary E. | director | Buy | 665 | - | May 19, 2026 |
| Jacks Tyler | director | Buy | 665 | - | May 19, 2026 |
| ISHRAK OMAR | director | Buy | 665 | - | May 19, 2026 |
| HOLLEY CHARLES M | director | Buy | 665 | - | May 19, 2026 |
| Garland Greg C. | director | Buy | 665 | - | May 19, 2026 |
| ECKERT ROBERT | director | Buy | 665 | - | May 19, 2026 |
| Druker Brian | director | Buy | 665 | - | May 19, 2026 |
| Drake Michael V | director | Buy | 665 | - | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AMGN Growth Story
Revenue YoY
9.9%
3yr Revenue CAGR
11.8%
EPS Growth YoY
88.23%
FCF Growth YoY
-22.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for AMGN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AMGN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:52 | $468.11 | 119,160 | $$55.8M | BUY |
| 21:28:25 | $468.11 | 8,424 | $$3.9M | BUY |
| 21:06:57 | $468.11 | 11,595 | $$5.4M | BUY |
| 21:00:37 | $468.11 | 1,194 | $$559K | BUY |
| 21:00:36 | $468.11 | 1,560 | $$730K | BUY |
5 dark pool trades shown · $$66.4M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for AMGN
PREVIEWSEPT Investing provides real-time options flow tracking for AMGN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $490 | Jan 15 | 65 | $$17.9K | 5 | SWEEP |
| PUT | $490 | Jan 15 | 65 | $$3570 | 1 | SWEEP |
| PUT | $490 | Jan 15 | 65 | $$7140 | 2 | SWEEP |
| PUT | $460 | Dec 18 | 37 | $$2850 | 2 | SWEEP |
| PUT | $460 | Dec 18 | 37 | $$1425 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About AMGN
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for AMGN. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup — $AMGN (AMGEN INC) Price: $438.34 | Zone: $433.42 — $441.76 Conviction: HIGH | Analyst upside: +-1.6% Near resistance (59% of range) — breakout watch. Positive news (8+ vs 6-). Earnings ...
Join 3,500+ traders discussing AMGN in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for AMGEN INC (AMGN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AMGN — frequently asked questions
What is AMGN stock price today?
AMGEN INC (AMGN) is at $468.11, up 0.62% (+$2.88) at the Nov 11, 2026 close.
Why is AMGN stock moving today?
Latest AMGN news — Nov 11, 2026: Amgen says late-stage trial of dazodalibep met goals in Sjögren's disease · Nov 11, 2026: Amgen experimental drug reduces symptoms in chronic autoimmune disease affecting tear production
Why did AMGN stock move on Nov 3, 2026?
Amgen reported strong third-quarter results and raised its full-year outlook, including lifting its FY2026 GAAP EPS guidance to $18.34-$19.28 from $15.80-$17.08, with the new midpoint above the $15.90 analyst estimate. The company also increased its FY2026 adjusted EPS outlook to $22.90-$23.70 and its sales forecast to $38.900B-$39.700B, both near or above analyst estimates.
What is the AMGN price target?
The average analyst price target for AMGN is $464.50, ranging from $398 to $536, based on 20 analysts. Latest: Freedom Broker downgrade on Nov 6, 2026.
What do analysts rate AMGN?
Analyst ratings for AMGN: 11 Buy, 18 Hold, 5 Sell — consensus Hold.
Did AMGN beat earnings?
AMGN last reported on Nov 3, 2026: EPS $6.45 vs $5.79 expected — a beat of 11.4%.
What is AMGN's P/E ratio?
AMGN trades at a P/E of 27.0 vs a Healthcare average of 17.1.
Does AMGN pay a dividend?
Yes. AMGN's dividend yield is 2.91%.
How much debt does AMGN have?
AMGEN INC reported $54.0B of debt and $13.2B of cash (Sep 30, 2026).
What are AMGN support and resistance levels?
Support: $447.04, $424.74, $409.00. Resistance: $475.64.
What are insiders doing with AMGN?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on AMGN?
Nov 11, 2026: Amgen says late-stage trial of dazodalibep met goals in Sjögren's disease · Nov 11, 2026: Amgen experimental drug reduces symptoms in chronic autoimmune disease affecting tear production · Nov 11, 2026: Amgen reports dazodalibep hit its primary endpoint at week 48